Antonio Ionescu

Antonio Ionescu

Auto-generated profile, based on publicly available information

Antonio Ionescu

“Dr. Ion Cantacuzino” Clinical Hospital, Bucharest, Romania

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2026 in Romanian Medical Journal
Verified
Journal Article
Open access
IPIuliana Pantelimon
Iuliana Pantelimon
FIFlorentina Ilie
Florentina Ilie
AIAntonio Ionescu
Antonio Ionescu
VMVlad Munteanu
Vlad Munteanu
DDDaniela Degeratu
Daniela Degeratu
ECEDUARD LUCIAN CATRINA
EDUARD LUCIAN CATRINA
Background. High-grade serous ovarian carcinoma is often diagnosed at an advanced stage, in which optimal cytoreduction, defined as no gross residual disease following surgery, is critical for survival. In patients with high tumor burden, neoadjuvant chemotherapy followed by interval debulking surgery is a valid alternative. Objectives. To describe a rare case of complete pathological response after neoadjuvant chemotherapy and its prognostic implications. Case report. A 75-year-old woman was diagnosed with FIGO stage IIIC high-grade serous ovarian carcinoma. Due to poor performance status and extensive disease, she received four cycles of platinum–taxane-based neoadjuvant chemotherapy, resulting in a complete radiologic response according to RECIST 1.1 criteria. Interval debulking surgery achieved complete cytoreduction, and histopathology confirmed a complete pathological response. Adjuvant and maintenance therapy were not administered, as the patient declined further treatment. After approximately six years of follow-up, the patient remains disease-free. Conclusions. Complete pathological response after neoadjuvant chemotherapy is rare and may predict prolonged disease-free survival, warranting further investigation into predictors of treatment response.